Genmab — Juni 2016
-
JNJ har solgt en del i 2016. Det er vel fra den amerikanske del
-
en stor del af bevælgelsen var også GSKs salg af deres 8% andel tilbage i starten af 2014
-
og det lader til at danmark+US tog deres del
-
specielt US interessen er interessant. Det er nok dem, der for alvor skal tage aktien til sig, for at vi kommer videre op
-
i øvrigt, så tror jeg at GEN blev 3'er i C20 regnskabet for det sidste halve år...
-
-
Går vi i plus?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind